So maybe the drug needs to be used in combination with a sensible diet and exercise regime, if the weight is to stay off
Visceral fat reduction improves waist-to-hip ratio
Long R3 IGF-1 has been studied and used for many years as a growth-supporting supplement in serum-free and reduced-serum media, including in industrial mammalian expression systems, where the practical questions are how much of it survives in medium over a culture cycle, whether it can substitute for insulin at far lower molar input, and how it interacts with the binding proteins that cells themselves secrete into conditioned medium
Clinical trials have demonstrated that Wegovy can help patients achieve substantial weight loss when combined with lifestyle interventions
"We want to reinforce that these drugs should be tried prior to GLP-1 agonists [for obesity treatment]," he said
The SURMOUNT-1 trial showed mean weight reductions of 15.0%, 19.5%, and 20.9% at the 5, 10, and 15 mg weekly doses over 72 weeks (Jastreboff et al., 2022)